1. Two batches of U.S. bond auctions on Monday had mixed results, with demand for two-year bonds weak and five-year bonds solid.
2. Expectations for the approval of the spot Bitcoin ETF are rising, and funds have flowed into digital assets for 9 consecutive weeks
3. The next "victim" of the green stock sell-off: Tesla is expected to fall out of the S&P 500 "TOP 10" next year!
4. Report shows Lilly's tilpotide is three times more effective than Novo Nordisk's meglutide
5. Analyst: iPhone 15 demand remains strong, especially in China

1. The two batches of U.S. bond auctions on Monday had mixed results, with demand for two-year bonds weak and five-year bonds solid.

The $54 billion two-year U.S. Treasury note posted a tailwind for the first time in four months, reflecting weak demand, with bid-to-bid ratios and allocations to overseas buyers both hitting eight-month lows. The US$55 billion five-year U.S. Treasury auction did not continue from the tail end of last month. The winning interest rate fell sharply by nearly 48 basis points from last month. The allocation ratio for overseas buyers also fell and was lower than the recent average.

2. "Dr. Doom" Roubini: High inflation will continue, and global investors may lose tens of trillions of dollars in the next 10 years

"Dr. Doom" Roubini said in an article last Friday that the world economy is facing an "era of great threats" and stagflation will become the core driver of headwinds in major markets. Globally, losses for bondholders and equity investors could rise to tens of trillions of dollars over the next decade. As for why inflation will remain high, he cited a host of threats, from an aging workforce to deglobalization and increased government spending in areas such as war and climate adaptation.

3. A strong rebound in 2023 will "slap" Wall Street in the face, and there will be little left for short sellers in U.S. stocks.

Wall Street strategists abandoned their usual bullish view on U.S. stocks as they entered 2023, only to be caught off guard by a strong rebound. Now, as usual, they are predicting annual growth for U.S. stocks next year. As Wall Street's most staunch short, Morgan Stanley strategist Mike Wilson's pessimistic forecast for this year has yet to come true. His outlook for next year has also become more positive. Although he believes the momentum behind the recent rally is losing, he expects the S&P 500 to reach 4,500 by the end of 2024, roughly where it is now.

4. Expectations for the approval of the spot Bitcoin ETF have increased, and funds have flowed into digital assets for nine consecutive weeks.

Rising expectations that the U.S. will eventually launch a physical Bitcoin exchange-traded fund (ETF) has prompted a ninth consecutive week of inflows into digital asset investment products, the largest inflows since the cryptocurrency bull run in late 2021. These products, such as trusts and exchange-traded products, saw $346 million in inflows last week, with Canada and Germany contributing 87% of the total, according to CoinShares. CoinShares reported that only $30 million came from the United States, indicating that participation from American investors remains low.

Related Opportunities: Coinbase

5. Saudi Arabia sought further support from OPEC+ for unilateral production cuts, but was opposed by some member states.

OPEC+ representatives said Saudi Arabia has been unilaterally cutting production by 1 million barrels per day since July and is now seeking further support from OPEC+. The Saudi proposal comes as OPEC faces difficult negotiations. Delegates said producers were moving toward a compromise before the weekend but had not yet reached an agreement.

Related opportunities: ExxonMobil, Chevron, BP

As of Monday's close, both the Dow Jones Industrial Average and the S&P Index had stopped rising for two consecutive days, falling to their highest levels in the past four months since August 7 and August 1 respectively, while the Nasdaq fell for two consecutive days.

NVIDIA stopped falling for three consecutive days, Amazon once rose more than 1% to a 19-month high, and Microsoft hit a new high. China Concept Index fell 1.6%, halting two days of consecutive gains, JD.com and Alibaba fell more than 1%, Xpeng Ideal Auto fell about 4%, and Douyu fell 8.6%.

1. The next "victim" of the green stock sell-off: Tesla is expected to fall out of the S&P 500 "TOP 10" next year!

According to the latest Markets Live Pulse survey, the recent wave of selling that has swept through green stocks looks set to continue into 2024, which would be the fourth consecutive year of declines for green stocks. This negative sentiment appears to be sweeping across the broader green asset class, with Tesla $TSLA potentially losing its status as a top-10 S&P 500 stock, according to reports.

2. Analyst: Demand for iPhone 15 remains strong, especially in China

Wedbush analyst Dan Ives said holiday season demand for Apple 's new iPhone 15 remains strong, especially in the Chinese market. "Despite the negative bear noise a few months ago, our Asia supply chain assessment for Apple's iPhone 15 remains very stringent heading into the important holiday season, particularly in China," he wrote in a note released on Friday. Region." As of press time, Apple was down slightly before the market opened.

3. Reports show that Lilly’s tilpotide is three times more effective than Novo Nordisk’s meglutide.

On Monday local time, the U.S. electronic health record (EHR) data and analysis company Truveta released a report stating that based on its research results, Eli Lilly’s $LLY Tirzepatide is more effective in weight loss than Novo Nordisk’s $NVO semaglu Three times the amount of peptide (Semaglutide). The data also showed that after 12 months of each treatment, the average weight loss in the tilpotide group was 15.2%, and the semaglutide group was 7.9%.

4. EU warns: Amazon’s acquisition of iRobot may harm market competition

Amazon's $ 1.4 billion deal to acquire iRobot is likely to fall through unless the two companies resolve a series of competition issues highlighted by EU antitrust authorities. The European Commission issued a so-called statement of objections on Monday, warning that Amazon's proposed deal could harm the market for the manufacture and supply of robot vacuum cleaners and allow the e-commerce giant to strengthen its position in online marketplaces and other data-related services. .

1. Taotian Group is preparing to build a large model team, with Dai Shan, Ruo Hai and Zheng Bo jointly taking charge.

Alibaba $09988.HK Taotian Group is preparing to build a large model research team and has started recruiting. It is reported that Taotian Group’s large-scale model research will mainly focus on two scenarios: one is search and promotion, and the other is content-based shopping. The team formation work was jointly led by Taotian Group CEO Dai Shan, Taotian Group CTO Ruohai, Alimama CTO Zheng Bo and others.

2. Hong Kong TVB announced that it will reorganize its television and e-commerce businesses and will lay off 300 people.

TVBroadcast $00511.HK According to the announcement, the board of directors announced the reorganization of the television broadcasting and e-commerce businesses, with a total reduction of more than 300 employees, equivalent to 8% of the total number of 3,599 employees at the end of June. In the TV broadcasting business, TVB plans to merge J2 (Channel 82) and Financial Sports Information Channel (Channel 85) into a new channel "TVB+". Together with cutting content costs, it is expected to lay off more than 200 people; in the e-commerce business, the group It is planned to merge "Shiduo" and "Linzhumai". Shiduo will be merged into Linzhumai, and 100 Shiduo employees will be left the group.

3. China Gas $00384.HK : Released interim results, with revenue of approximately HK$36.049 billion and net profit of HK$1.83 billion. Total natural gas sales in the first half of the fiscal year increased by 1.7% to 16.97 billion cubic meters.

4. Beisen Holdings $09669.HK : Released interim results. Revenue during the period was 401 million yuan, a year-on-year increase of 14.2%; loss was 3.058 billion yuan, a year-on-year increase of 1778.2%.

5. Henlius $02696.HK : The clinical trial application for HLX4 for injection in the treatment of advanced/metastatic solid tumors was approved by the US Food and Drug Administration (FDA).

6. Yuanda Pharmaceutical $00512.HK : The first patient has been enrolled in the phase II clinical study of the global innovative product STC3141 in China.

7. CSPC $01093.HK : The highly selective SOS1 inhibitor (SYH2038) developed by CSPC was approved for clinical trials.

Hong Kong Stock Earnings Report

Meituan-W $03690.HK

Alibaba Health $00241.HK

China Want Want $00151.HK

US stock earnings report

Pinduoduo $PDD | Pre-market

Canaan Technology $CAN | Pre-market

CrowdStrike $CRWD | After Hours

Intuit $INTU | After Hours

Tuya Smart $TUYA | After-hours

New US stocks

Fenbo Holdings Ltd $FEBO

The above is today’s Washington Morning Post. Welcome to leave a message for discussion. I wish you good luck with your investment!

Risk Warning: Investment involves risks. Securities prices may rise or fall, and may become worthless. Investment may not necessarily earn profits, but may result in losses. Past performance is not indicative of future performance. Before making any investment decision, investors must evaluate their financial situation, investment objectives, experience, risk tolerance and understand the nature and risks of the relevant products. For details on the nature and risks of individual investment products, please read the relevant sales documents for more information. If in any doubt, independent professional advice should be obtained.

.